IHH Healthcare
IHH Healthcare Berhad is a prominent international healthcare services provider based in Kuala Lumpur, Malaysia. The company offers a comprehensive range of healthcare services, including primary care for basic illnesses, secondary services such as specialist consultations and emergency care, and tertiary and quaternary care involving complex surgeries and inpatient services. IHH Healthcare operates approximately 15,000 licensed beds across 77 hospitals in multiple countries, primarily in Asia and Central & Eastern Europe, the Middle East, and North Africa. The company is recognized as a leading player in its core markets of Singapore, Malaysia, and Turkey, as well as in China, Hong Kong, and India. In addition to its hospital operations, IHH Healthcare provides ancillary services like diagnostic testing and rehabilitation, and is involved in medical education. Established in 2010, it continues to emphasize patient-centric care, aiming to enhance the healthcare experience and accessibility for its patients.
9 past transactions
Island Hospital
Acquisition in 2024
Island Hospital is a healthcare organization based in Malaysia that offers a wide range of medical services, including diagnostics, surgery, and treatment for patients of all ages. The hospital is equipped with advanced medical technology and equipment, which enhances its ability to provide effective health screening and clinical investigations. By leveraging these resources, Island Hospital aims to ensure that patients have access to specialists and receive timely, same-day results, all while maintaining affordability in its services.
Intellect
Corporate Round in 2023
Intellect Company Pte. Ltd., established in 2019 and based in Singapore, operates a psychological mental health platform designed to enhance mental well-being. The platform integrates technology and human interaction to provide accessible support for individuals facing various challenges such as procrastination, low self-esteem, and anxiety. Through its app, Intellect offers digitized therapy programs developed by leading psychologists and behavioral experts, helping users to redevelop traits, habits, and behaviors. The company's mission is to lower barriers to mental health support, creating a straightforward and effective journey for users to address personality flaws and improve their overall confidence and social skills.
Doctor Anywhere
Series C in 2022
Doctor Anywhere is a Singapore-based telehealth company that provides on-demand healthcare solutions. Its digital platform offers quick access to health and wellness services, optimized for convenient lifestyle management.
Us2.ai
Series A in 2022
Us2.ai is a Singapore-based company that specializes in developing software and digital tools for echocardiography using artificial intelligence. The company's platform automates the manual process of measuring and interpreting echocardiograms, which are ultrasound images of the heart. This automation provides decision support tools designed to save doctors time, improve clinical trials for pharmaceutical companies, and enhance the detection of hard-to-diagnose cardiovascular conditions in hospitals. Us2.ai aims to simplify access to results of echo analysis and heart ultrasound through its online solutions.
Doctor Anywhere
Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that provides on-demand healthcare solutions. Its digital platform offers quick access to health and wellness services, optimized for convenient lifestyle management.
Lucence Diagnostics
Series A in 2019
Founded in Singapore in 2016, Lucence Diagnostics develops and manufactures liquid biopsy tests for early detection and monitoring of various cancers. Its portfolio includes tests like LiquidHALLMARK, LiquidSCREEN, LiquidTRACK, LumiBRCATM, LumiTHERA, and FibroPhyllo, targeting nasopharyngeal, breast, ovarian, and other cancers. The company also develops SunTzu.AI, a clinical software for cancer analysis and treatment.
Angsana Molecular & Diagnostic Laboratory
Acquisition in 2017
Angsana Molecular & Diagnostics is a multinational company based in Singapore that specializes in advanced genomic assays tailored to address the health needs of the Asian population. The laboratory focuses on molecular diagnostics and predictive pathology, developing laboratory-developed assays in key areas such as allergy, fetal and maternal health, molecular oncology, and pharmacogenomics. By providing comprehensive analysis of medical conditions at a molecular level, Angsana empowers clinicians with valuable insights for accurate diagnosis and personalized treatment options. This approach enables both doctors and patients to make informed decisions regarding disease management, enhancing the overall effectiveness of healthcare delivery.
Gleneagles Global Hospitals
Acquisition in 2015
Gleneagles Global Hospitals, part of Ravindranath GE Medical Associates Private Ltd, operates a network of five hospitals across major Indian cities, including Hyderabad, Bangalore, Chennai, and Mumbai, with a current capacity of approximately 1,100 operational beds. The organization is recognized for its specialization in multi-organ transplantation services, offering comprehensive care for liver, heart, lung, kidney, and bone marrow transplants. In addition to transplantation, Gleneagles Global Hospitals provides a range of health screenings and specialty care, addressing conditions related to knee, gastric, cardiac, and breast cancer. The company anticipates expanding its capacity to around 1,900 beds within the next five years, further enhancing its ability to deliver advanced medical services.
Fortis Healthcare
Acquisition in 2014
Founded in 1995, Fortis Healthcare is a leading integrated healthcare provider operating across Asia-Pacific. It offers secondary to quaternary care through its network of hospitals, diagnostics centers, and day care specialty facilities. As of March 2020, Fortis operated approximately 4,000 beds across 36 healthcare facilities, along with 415 diagnostic centers and laboratories.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.